EUVIMEDEUVIMED entdecken
Open Access

Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest

Okan Onar iD, Pelin Telkoparan-Akillilar iD, Ozlem Yildirim iD

3 Biotech · 2023-02 · 13 (2)

DOI: 10.1007/s13205-023-03471-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift 3 Biotech, online erschienen am 13.01.2023. Verfasst von Okan Onar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ankara Universitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although 5-fluorouracil (5-FU) is an important anticancer agent for the treatment of colorectal cancer, drug resistance, and dose-related side effects limit the effectiveness of the treatment. Therefore, developing new pharmaceuticals with effective and low toxicity is critically necessary for cancer therapy. This study aimed to investigate the cytotoxic activity of the Clitocybe nebularis mushroom extract (CN) on HT-29 human colon cancer cells. A series of in vitro experiments were performed on the HT-29, Caco-2, and HEK-293 cells, which includes cytotoxicity, drug interaction, colony formation, cell cycle, and migration assays. In addition, qRT-PCR experiment was also performed to investigate the potential molecular mechanisms of action of CN on the proliferation of colon cancer cell line. Our results show that CN exhibited selective cytotoxic activity on HT-29 and Caco-2 colon cancer cells, whereas no cytotoxic effect was observed on normal HEK-293 cells. With the combination of CN and 5‑FU, their cytotoxic activity on HT-29 cells was significantly increased compared to their use alone. In addition, the combination of CN and 5-FU also showed synergistic anticancer activity through cell cycle arrest in the S phase. The results also show that p21, p27, and p53 expression levels increased as a result of CN treatment. Our in vitro findings show that CN has a synergistic effect with 5-FU by inhibiting cell proliferation of colon cancer cells and inducing cell cycle arrest in the S phase.

Schlagwörter

Stichwörter der Autor:innen

5-fluorouracilAnticancerCell-cycle arrestClitocybe nebularisColorectal carcinoma

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Yuksek Ihtisas University, Ankara, Turkey.

ORCID-Profile: Okan Onar, Pelin Telkoparan-Akillilar, Ozlem Yildirim

Förderung

  • Ankara Universitesi

Zitieren

APA

Onar, O., Telkoparan-Akillilar, P., & Yildirim, O. (2023). Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech, 13(2). https://doi.org/10.1007/s13205-023-03471-9

Vancouver

Onar O, Telkoparan-Akillilar P, Yildirim O. Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech. 2023;13(2). doi:10.1007/s13205-023-03471-9

BibTeX
@article{Onar2023,
  author = {Onar, Okan and Telkoparan-Akillilar, Pelin and Yildirim, Ozlem},
  title = {Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest},
  journal = {3 Biotech},
  year = {2023},
  volume = {13},
  number = {2},
  doi = {10.1007/s13205-023-03471-9}
}
Kostenlos starten →